Mark C Berry

9PUBLICATIONS
67CO-AUTHORS
Respiratory diseasesPatient safetySocial determinants of healthPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 01, 2026
Retrospective Cohort Study Assessing Remdesivir Effectiveness in Hospitalized COVID-19 Patients With Renal or Hepatic Comorbidities.

|Apr 27, 2026
Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

|Oct 18, 2024
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals.

Essy Mozaffari, Aastha Chandak, Mark Berry

|Oct 15, 2024
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb

|Oct 15, 2024
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb

|Sep 20, 2024
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb

Pageof 2

Frequent Collaborators

6 joint publications

Aastha Chandak

5 joint publications

Robert L Gottlieb

5 joint publications

Chidinma Chima-Melton

5 joint publications

Andre C Kalil